Martine Clozel

Last updated

Martine Clozel (born 27 December 1955) is a scientist, entrepreneur and co-founder of Actelion and Idorsia. [1]

Contents

Education and career

Clozel studied at the University of Nancy and the University of California in San Francisco. She also attended further training in physiology and pharmacology at McGill University. [2]

In 1997, she founded Actelion with her husband Jean-Paul Clozel. [3] [4] The company was sold in 2017 to the American pharmaceutical and consumer products company Johnson & Johnson for US$30 billion. [5] Martine Clozel founded the pharmaceutical company Idorsia in 2017 and has since served as head of research. She is one of the most successful female company founders in Switzerland. [6]

Awards

Related Research Articles

<span class="mw-page-title-main">Johnson & Johnson</span> American multinational pharmaceutical and consumer goods corporation

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

<span class="mw-page-title-main">Micheline Calmy-Rey</span> 89th President of the Swiss Confederation

Micheline Anne-Marie Calmy-Rey is a Swiss politician who served as a Member of the Swiss Federal Council from 2003 to 2011. A member of the Social Democratic Party (SP/PS), she was the head of the Federal Department of Foreign Affairs during her tenure as a Federal Councillor. She was President of the Swiss Confederation twice, in 2007 and 2011.

<span class="mw-page-title-main">Banking in Switzerland</span>

Banking in Switzerland dates to the early eighteenth century through Switzerland's merchant trade and has, over the centuries, grown into a complex, regulated, and international industry. Banking is seen as emblematic of Switzerland. The country has a long history of banking secrecy and client confidentiality reaching back to the early 1700s. Starting as a way to protect wealthy European banking interests, Swiss banking secrecy was codified in 1934 with the passage of the landmark federal law, the Federal Act on Banks and Savings Banks. These laws, which were used to protect assets of persons being persecuted by Nazi authorities, have also been used by people and institutions seeking to illegally evade taxes, hide assets, or generally commit financial crime.

<span class="mw-page-title-main">Credit Suisse</span> Swiss multinational bank

Credit Suisse Group AG is a global investment bank and financial services firm founded and based in Switzerland. Headquartered in Zürich, it maintains offices in all major financial centers around the world and provides services in investment banking, private banking, asset management, and shared services. It is known for strict bank–client confidentiality and banking secrecy. The Financial Stability Board considers it to be a global systemically important bank. Credit Suisse is also a primary dealer and Forex counterparty of the Federal Reserve in the United States.

<span class="mw-page-title-main">Ernesto Bertarelli</span> Swiss-Italian billionaire

Ernesto Silvio Maurizio Bertarelli is an Italian-born Swiss billionaire businessman and philanthropist.

<span class="mw-page-title-main">Sibylle Berg</span> Swiss author and playwright (born 1962)

Sibylle Berg is a German-Swiss contemporary author and playwright. They write novels, essays, short fiction, plays, radio plays, and columns. Their 15 books have been translated into 30 languages. They have won numerous awards, including the Thüringer Literaturpreis, the Bertolt-Brecht-Literaturpreis, and the Johann-Peter-Hebel-Preis. They have become an iconic figure in German alternative sub-cultures, gaining a large fan base among the LGBT community and the European artistic communities. They live in Switzerland and Israel. Their 2019 work GRM. Brainfuck, a science fiction novel set in a dystopian near future won the Swiss Book Prize, and reached fourth place on the Spiegel Bestseller list, with the sequel, RCE, entering the list as highest entry of the week at place 14. March 1st 2023 Berg was invited as special guest to open the high profile Elevate Festival in Graz.

<span class="mw-page-title-main">Russia–Switzerland relations</span> Bilateral relations

Russia–Switzerland relations are foreign relations between Russia and Switzerland. Switzerland opened a consulate in Saint Petersburg in 1816, upgrading it to a legation 90 years later. The two countries broke off diplomatic relations in 1923, when Russia was going through a period of revolutionary turmoil – and they were not resumed until 1946.

<span class="mw-page-title-main">Iran–Switzerland relations</span> Bilateral relations

Iran–Switzerland relations are foreign relations between the Islamic Republic of Iran and the Swiss Confederation.

<span class="mw-page-title-main">Ulrich Körner</span> German-Swiss business person (born 1962)

Ulrich Körner is a German-Swiss business person. In March 2021, he was named CEO Asset Management of Credit Suisse until July 2022, when he was appointed CEO of Credit Suisse AG.

Switzerland participated at the Eurovision Song Contest 2010 with the song "Il pleut de l'or" written by Michael von der Heide, Pele Loriano and Heike Kospach. The song was performed by Michael von der Heide, who was internally selected by the Swiss broadcaster SRG SSR idée suisse to represent the nation at the 2010 contest in Oslo, Norway. "Il pleut de l'or" was announced as the Swiss entry on 18 December 2009, while the song was presented to the public on 9 January 2010.

<span class="mw-page-title-main">UBS</span> Multinational investment bank

UBS Group AG is a multinational investment bank and financial services company founded and based in Switzerland. Co-headquartered in the cities of Zürich and Basel, it maintains a presence in all major financial centres as the largest Swiss banking institution and the largest private bank in the world. UBS client services are known for their strict bank–client confidentiality and culture of banking secrecy. Because of the bank's large positions in the Americas, EMEA, and Asia Pacific markets, the Financial Stability Board considers it a global systemically important bank.

<span class="mw-page-title-main">Actelion</span> Swiss biopharmaceutical company

Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.

<span class="mw-page-title-main">Pharmaceutical industry in Switzerland</span> Overview of the pharmaceutical industry in Switzerland

The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes to 5.7% of the gross domestic product of Switzerland and contributes to 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.

<span class="mw-page-title-main">Gardi Hutter</span>

Gardi Hutter is a Swiss Clown-comedian, author, actress and Cabaret artist and a clown of the classical rule.

<span class="mw-page-title-main">Cargo Sous Terrain</span>

Cargo Sous Terrain is a planned underground logistics system in Switzerland. It was set up as an association in September 2013, and was based at the headquarters of the Swiss retailer Coop in Basel. It converted itself into a share company on 24 March 2017.

Michael Otmar Hengartner is a Swiss-Canadian biochemist and molecular biologist. From February 2020 he has been president of the ETH Board. Before that he was the president of the University of Zurich and president of the Swiss Rectors' Conference, swissuniversities.

<span class="mw-page-title-main">Özlem Türeci</span> German physician, scientist and entrepreneur

Özlem Türeci is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021, she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse, Uğur Şahin, have won a number of awards.

<span class="mw-page-title-main">Owkin</span>

Owkin is a medical A.I. company created in 2016 that develops a federated learning A.I. platform to help pharmaceutical companies discover new drugs. Owkin has collaborated with Amgen to demonstrate the ability of A.I. to improve cardiovascular prediction.

Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. After Actelion was bought by Johnson & Johnson in 2017, the Actelion founders, Jean-Paul and Martine Clozel, started their new business, located just across the road from the Actelion headquarters. The company expects to be profitable in 2025.

The 2022–23 Swiss Super League is the 126th season of top-tier competitive football in Switzerland and the 20th under its current name and format. With this season, the Swiss Super League became the longest continuously running top-flight national league.

References

  1. "Idorsia Pharmaceuticals Ltd: Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by". bloomberg.com. 13 November 2022. Retrieved 14 December 2022.
  2. "More entrepreneurship – Courageous transformations". idorsia.com. Retrieved 14 December 2022.
  3. Denise Roland (2 March 2017). "Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm". wsj.com. Retrieved 14 December 2022.
  4. Pascal Züger (13 June 2018). "Das ist die Frau hinter dem Erfolg von Idorsia und Actelion". cash.ch. Retrieved 14 December 2022.
  5. John Miller (26 January 2017). "Medical couple and butcher's boy win big from Actelion sale". reuters.com. Retrieved 14 December 2022.
  6. Karen Merkel-Gyger (22 August 2018). ""Wir wissen genau, wo wir in fünf Jahren sein wollen"". handelszeitung.ch. Retrieved 14 December 2022.
  7. "Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by Initiative Switzerland with the Annual Prix Suisse Award". globenewswire.com. 13 November 2022. Retrieved 14 December 2022.
  8. Dominik Fischer (13 November 2022). "Martine Clozel geehrt – "sie verändert das Leben von Patienten weltweit"". 20min.ch. Retrieved 14 December 2022.